In the News – January 2017
Every day, we monitor what the media are talking about in the U-I space. In addition to posting articles of interest on our LinkedIn group, we also share In the News articles here. Keep checking back. We update this post regularly.
Week of January 30
With grads gravitating toward tech firms, leaders of firms like Cargill, Land O’Lakes spend more time on campus
UIDP Members UT Austin and Lockheed Martin will continue a longstanding partnership to support modern engineering research.
Throughout its nearly 180-year history, John Deere has been an innovation leader. Its first product was a polished-steel plow that outperformed existing tools. And over the decades, the company’s research and development (R&D) efforts were aimed squarely at improving the mechanical and functional performance of its products. Today, Deere’s iconic green machinery is recognized the world over for quality and durability. But over the last decade, the focus of the company’s R&D has been shifting to software and service offerings.
Week of January 23
Though the idea may hold intuitive appeal, its very existence has been questioned, and it has been plagued by fuzzy definitions. It’s not always clear which skills, specifically, are lacking. Sometimes they’re technical ones, like managing a robotics operation on a factory floor or using Excel in a cubicle. Sometimes it’s so-called soft skills, like critical thinking or communicating well. Other times, the skills gap refers to dispositions like work ethic, persistence, or the ability to collaborate as part of a team.
If you have identified an interesting opportunity for a research or development collaboration and are discussing a potential agreement, then Intellectual Property (IP) is one of the key factors that will need your consideration. This article provides clear, practical guidance on how to approach the key IP issues that can arise before, during and after such collaborations.
It is not yet known whether Trump will permanently reappoint Collins to be his NIH director for his full term. Collin’s office directed all further questions to the Trump transition.
The National Science Foundation (NSF) announces the participation of cloud providers, including Amazon Web Services (AWS), Google, and Microsoft, in its flagship research program on big data, Critical Techniques, Technologies and Methodologies for Advancing Foundations and Applications of Big Data Sciences and Engineering (BIGDATA). AWS, Google, and Microsoft will provide cloud credits/resources to qualifying NSF-funded projects, enabling researchers to obtain access to state-of-the-art cloud resources.
The OMIC is a collaborative environment bringing together industry, higher education and government in partnership to develop new tools, technique, and technologies to address near-term manufacturing challenges through applied research and advanced technical training. OMIC is modeled after The University of Sheffield Advanced Manufacturing Research Centre (AMRC) at University of Sheffield with Boeing in Sheffield, England.
The U.S. Department of Health and Human Services and 15 other federal agencies have issued a final rule to update the “Common Rule” regulations that safeguard individuals who participate in research.
Atlanta Mayor Kasim Reed, the Georgia Institute of Technology and the CEOs of 10 of Atlanta’s leading corporations today jointly announced the launch of Engage, a mentorship-driven accelerator program and venture fund.
Week of January 16
Under Armour is drawing on expertise from Johns Hopkins Medicine to further develop the fitness apps that the company has been acquiring and launching over the last couple of years.
Week of January 9
To bring clarity to these unsure times, FasterCures has compiled a list of issues critical to the future of medical innovation that we’ll be tracking over the coming year.
Trump has been clear that he wants to lower the cost of drugs and reform the FDA, presumably beyond what’s laid out in 21st Century Cures. But rather than continue to add new layers on top of a drug development system created for a long-gone era, I urge the soon-to-be president to consider how we can rebuild the system for the future — a time when drug development is no longer beholden to Byzantine requirements and a company doesn’t have to spend billions of dollars to get a drug to the market.
The dietary supplements had ominous names, like Black Widow and Yellow Scorpion. They contained an illegal and potentially dangerous molecule, similar in structure to amphetamines.
But when a Harvard researcher dared to point that out, in a scientific, peer-reviewed study and in media interviews, the supplement maker sued him for libel and slander.
Any stimulus program needs to focus more on “innovation infrastructure,” such as scientific and engineering research, than on traditional concrete and steel.
Week of January 2
Adjusted for inflation, R&D budget authority remains below FY 2010 levels
Vice President Biden, who led the Obama administration’s “cancer moonshot” initiative, will create a nonprofit organization to grapple with a broad range of cancer issues, including the high cost of cancer drugs, he said in an interview Wednesday.
First things first: Food and Drug Commissioner Robert Califf says that he has not had any contact with the Trump transition team. That’s the latest sign that the cardiologist, confirmed as FDA chief less than a year ago, will be heading back to Durham, N.C., where he’s on leave from Duke University. Still, he has no regrets: “Everyone who knows me knows I have just had fun every day on the job,” he said in an interview.